Gayet-Ageron Angèle, Ben Messaoud Khaoula, Richards Mark, Jaksic Cyril, Gobeill Julien, Liyanapathirana Jeevanthi, Mottin Luc, Naderi Nona, Ruch Patrick, Mariot Zoé, Calmy Alexandra, Friedman Julia, Leibovici Leonard, Schroter Sara
Division of Clinical Epidemiology, University Hospitals Geneva, Geneva, Switzerland
Department of Health and Community Medicine, University of Geneva, Geneva, Switzerland.
BMJ Evid Based Med. 2025 May 20;30(3):149-162. doi: 10.1136/bmjebm-2024-113083.
To assess whether the gender (primary) and geographical affiliation (post-hoc) of the first and/or last authors are associated with publication decisions after peer review.
Case-control study.
Biomedical journals.
Original peer-reviewed manuscripts submitted between 1 January 2012 and 31 December 2019.
Manuscripts accepted (cases) and rejected for publication (controls).
Of 6213 included manuscripts, 5294 (85.2%) first and 5479 (88.1%) last authors' gender were identified; 2511 (47.4%) and 1793 (32.7%) were women, respectively. The proportion of women first and last authors was 48.4% (n=1314) and 32.2% (n=885) among cases and 46.4% (n=1197) and 33.2% (n=908) among controls. After adjustment, the association between the first author's gender and acceptance for publication remained non-significant 1.04 (0.92 to 1.17). Acceptance for publication was lower for first authors affiliated to Asia 0.58 (0.46 to 0.73), Africa 0.75 (0.41 to 1.36) and South America 0.68 (0.40 to 1.16) compared with Europe, and for first author affiliated to upper-middle country-income 0.66 (0.47 to 0.95) and lower-middle/low 0.69 (0.46 to 1.03) compared with high country-income group. It was significantly higher when both first and last authors were affiliated to different countries from same geographical and income groups 1.35 (1.03 to 1.77), different countries and geographical but same income groups 1.50 (1.14 to 1.96) or different countries, geographical and income groups 1.78 (1.27 to 2.50) compared with authors from similar countries. The study funding was independently associated with the acceptance for publication (when compared with no funding, 1.40; 1.04 to 1.89 for funding by association & foundations, 2.76; 1.87 to 4.10 for international organisations, 1.30; 1.04 to 1.62 for non-profit & associations & foundations). The reviewers' recommendations of the original submitted version were significantly associated with the outcome (unadjusted 5.36; 4.98 to 5.78 for acceptance compared with rejection). Gender of the first author was not associated with reviewers' recommendations (adjusted 0.96, 0.87 to 1.06).
We did not identify evidence of gender bias during the editorial decision-making process for papers sent out to peer review. However, the under-representation in manuscripts accepted for publication of first authors affiliated to Asia, Africa or South America and those affiliated to upper/lower-middle and low country-income group, indicates poor representation of global scientists' opinion and supports growing demands for improving equity, diversity and inclusion in biomedical research. The more diverse the countries and incomes of the first and last authors, the greater the chances of the publication being accepted.
评估第一作者和/或最后作者的性别(主要因素)及所属地区(事后分析因素)与同行评审后的发表决策是否相关。
病例对照研究。
生物医学期刊。
2012年1月1日至2019年12月31日期间提交的经同行评审的原创稿件。
稿件被接受发表(病例组)和被拒稿(对照组)。
在纳入的6213篇稿件中,确定了5294名(85.2%)第一作者和5479名(88.1%)最后作者的性别;其中分别有2511名(47.4%)和1793名(32.7%)为女性。病例组中第一作者和最后作者为女性的比例分别为48.4%(n = 1314)和32.2%(n = 885),对照组中分别为46.4%(n = 1197)和33.2%(n = 908)。调整后,第一作者性别与发表接受之间的关联仍不显著,比值比为1.04(0.92至1.17)。与欧洲相比,来自亚洲的第一作者发表接受率较低,为0.58(0.46至0.73),非洲为0.75(0.41至1.36),南美洲为0.68(0.40至1.16);与高收入国家组相比,来自中高收入国家的第一作者发表接受率为0.66(0.47至0.95),中低收入/低收入国家为0.69(0.46至1.03)。当第一作者和最后作者来自不同国家但属于相同地理和收入组时,发表接受率显著更高,比值比为1.35(1.03至1.77);来自不同国家和地理但相同收入组时为1.50(1.14至1.96);来自不同国家、地理和收入组时为1.78(1.27至2.50),相比之下来自相似国家的作者情况则不同。研究资金与发表接受独立相关(与无资金相比,比值比为1.40;协会和基金会资助时为1.04至1.89,国际组织资助时为2.76;1.87至4.10,非营利组织、协会和基金会资助时为1.30;1.04至1.62)。原始提交版本的审稿人建议与结果显著相关(未调整时,接受与拒稿相比,比值比为5.36;4.98至5.78)。第一作者性别与审稿人建议无关(调整后比值比为0.96,0.87至1.06)。
我们未发现同行评审稿件编辑决策过程中存在性别偏见的证据。然而,在被接受发表的稿件中,来自亚洲、非洲或南美洲的第一作者以及来自中高/中低和低收入国家组的第一作者代表性不足,这表明全球科学家的意见未得到充分体现,并支持了对改善生物医学研究公平性、多样性和包容性的日益增长的需求。第一作者和最后作者的国家和收入越多样化,稿件被接受发表的机会就越大。